Diagnostic Biomarkers and Imaging Modalities in Long COVID: Toward Precision Detection and Monitoring

November 23, 2025 | John Murphy | Leave a Comment

Diagnostic Biomarkers and Imaging Modalities in Long COVID: Toward Precision Detection and Monitoring

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), presents with a complex array of symptoms affecting multiple organ systems. Accurate diagnosis…[...]

August 8, 2025 | John Murphy | Leave a Comment

COVID-19 coagulopathy, thrombosis, and bleeding

Noel C. Chan, Jeffrey I. Weitz, Blood (2020) 136 (4): 381–383.https://doi.org/10.1182/blood.2020007335 In this issue of Blood, Al-Samkari et al expand our understanding of thrombosis and bleeding risks and their predictors in hospitalized patients with…[...]

May 25, 2025 | John Murphy | Leave a Comment

Post-COVID-19 Inflammatory Arthritis Treated With Upadacitinib: A Case Report

Cherie S. Zhi • Ami Ben-Artzi, DOI: 10.7759/cureus.78799 Abstract Two patients who developed inflammatory arthritis following COVID-19 infection are presented, characterized by arthralgias, arthritis, and elevated markers of inflammation (C-reactive protein). Both patients…[...]

May 11, 2025 | John Murphy | Leave a Comment

An Alarming Sign: Acute Limb Ischemia in Patients With COVID-19

Mohd Faris B. Mohd Aladin • Rosenelifaizur Ramely, DOI: 10.7759/cureus.80798 Abstract Acute limb ischemia (ALI) can occur as a late complication in patients recovering from COVID-19. Although typically seen during the acute phase,…[...]

March 21, 2025 | John Murphy | Leave a Comment

Liver Enzymes and Inflammatory Markers Among Severely Ill COVID-19 Patients: A Retrospective Case-Control Study in Telangana

Pavuluri P, Menon M, Tummalacharla S, et al. (December 04, 2024) Liver Enzymes and Inflammatory Markers Among Severely Ill COVID-19 Patients: A Retrospective Case-Control Study in Telangana. Cureus 16(12): e75120.…[...]

December 2, 2024 | John Murphy | Leave a Comment

Predicting the Need for Advanced Respiratory Support in COVID-19 Patients During the Initial Pandemic Phase: A Retrospective Analysis

Tuğba Çiçek • Melahat Uzel Sener • Ayperi Öztürk, Published:, 2024, DOI: 10.7759/cureus.64678 Abstract Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to high morbidity and…[...]

September 27, 2024 | John Murphy | Leave a Comment

Dynamic Assessment of Hematological Parameters as Predictive Biomarkers for Disease Severity and Prognosis in COVID-19 Patients: A Longitudinal Study

Aparna P. Patange • Jabbar V. Desai • Bhupal Pujari • Aparna Marwah • Animesh Dey, Published: July 01, 2024, DOI: 10.7759/cureus.63593 Abstract Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has…[...]

August 22, 2024 | John Murphy | Leave a Comment

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches

Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc2 , et. al., Front. Immunol., 03 March 2024, Sec. Viral Immunology, Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1344086 The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has…[...]

November 18, 2023 | John Murphy | Leave a Comment

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Maxime Taquet, Zuzanna Skorniewska, Adam Hampshire, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Raman, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Aarti Shikotra, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Linzy Houchen-Wolloff, Neil J. Greening, Parisa Mansoori, Ewen M.…[...]

October 25, 2023 | John Murphy | Leave a Comment

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?

Dominique Comeau1† Mykella Martin2† Gilles A. Robichaud3,4,5 Ludivine Chamard-Witkowski2,6*1Dr. Georges-L. Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection. Patients suffering…[...]